| 000 | 01850 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516003153.0 | ||
| 264 | 0 | _c20110614 | |
| 008 | 201106s 0 0 eng d | ||
| 022 | _a1554-8619 | ||
| 024 | 7 |
_a10.4161/hv.6.10.12582 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLarnaudie, Sylvie | |
| 245 | 0 | 0 |
_aHumoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history. _h[electronic resource] |
| 260 |
_bHuman vaccines _cOct 2010 |
||
| 300 |
_a829-34 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Bacterial _xblood |
| 650 | 0 | 4 |
_aAntibodies, Viral _xblood |
| 650 | 0 | 4 |
_aDiphtheria Toxoid _xadministration & dosage |
| 650 | 0 | 4 |
_aDiphtheria-Tetanus-Pertussis Vaccine _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFrance |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization Schedule |
| 650 | 0 | 4 |
_aImmunization, Secondary _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPertussis Vaccine _xadministration & dosage |
| 650 | 0 | 4 |
_aPoliovirus Vaccine, Inactivated _xadministration & dosage |
| 650 | 0 | 4 |
_aPoliovirus Vaccines _ximmunology |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aTetanus Toxoid _xadministration & dosage |
| 650 | 0 | 4 |
_aVaccination _xmethods |
| 650 | 0 | 4 |
_aVaccines, Combined _ximmunology |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aGuiso, Nicole | |
| 700 | 1 | _aBaptiste, Charles | |
| 700 | 1 | _aDesaint, Corinne | |
| 700 | 1 | _aDesforges, Lionel | |
| 700 | 1 | _aLebon, Pierre | |
| 700 | 1 | _aSoubeyrand, Benoit | |
| 700 | 1 | _aLaunay, Odile | |
| 773 | 0 |
_tHuman vaccines _gvol. 6 _gno. 10 _gp. 829-34 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4161/hv.6.10.12582 _zAvailable from publisher's website |
| 999 |
_c20194672 _d20194672 |
||